home contact company.overview news sitemap print
9-well MEA chip for parallel drug testing
MEA-Cardiosensor
Do you need a relevant and robust cell model for drug safety testing?
The assay is based on the extracellular recording of field action potentials (fAPs) of cardiomyocytes in culture with microelectrode arrays (MEAs).
fAPs reflect the concerted activation and inactivation of cardiac ion channels, comparable to an electrocardiogram (ECG) in patients and are thus referred to here as “QT-interval” in vitro.
|
||||||||||||||